InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,877.60
(
0.43%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.44
(
-0.18%
)
Bitcoin
63,046.47
(
3.73%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gaboy47

Send PM Follow Ignore
Followers 22
Posts 1965
Boards Moderated 0
Alias Born 06/15/2005

gaboy47

Re: bocxman post# 3147

Friday, 04/21/2006 6:34:11 AM

Friday, April 21, 2006 6:34:11 AM

Post# of 30387
Bocxman & Kag:

Have 2 questions for you guys.

1.) If Abbott were able to ink an exclusive agreement with Biocurex, why would they license the technology to their competitors. I just don't see Biocurex giving Abbott full control of their technology.

2.) How does Abbott incorporate a new FDA approved test into the analyzers already in use. Do the hospital's/labs purchase an upgrade at an additional cost.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up